Efficacy of ezetimibe on improvement of glucose metabolism in Japanese subjects with type 2 diabetes

Efficacy of ezetimibe on improvement of glucose metabolism in Japanese subjects with type 2 diabetes - Efficacy of ezetimibe on improvement of glucose metabolism

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005307

Enrollment

100

Registered

2011-03-28

Start date

2009-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes with hypercholesterolemia

Interventions

ezetiibe 10mg/day po

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 diabetes with hypercholesterolemia

Exclusion criteria

Exclusion criteria: Past alcohol intake of more than 20g/day serological evidence of viral hepatitis hemochromatosis autoimmune liver disease non-alcoholic steatohepatitis (NASH)

Design outcomes

Primary

Measure	Time frame
Decrease of HbA1c	—

Secondary

Measure	Time frame
Decrease of LDL-C	—

Countries

Japan

Contacts

Public ContactSeiya Shimoda

Faculty of Life Sciences, Kumamoto University Department of Metabolic Medicine

sshimoda@gpo.kumamoto-u.ac.jp097-373-5169

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026